Zilbrysq's Price Point
Zilbrysq, a medication approved for progressive forms of multiple sclerosis, has a list price of $8,799.84 per month [1]. This translates to an annual cost of approximately $105,598 [1].
What Factors Influence Zilbrysq's Cost?
The pricing of Zilbrysq, like other specialty drugs, is influenced by several factors. These include the research and development expenses incurred by the manufacturer, the drug's clinical effectiveness and uniqueness in treating the condition, and market dynamics, including competition and patient access programs [1].
How Can Patients Afford Zilbrysq?
For eligible patients, support programs may be available to help manage the cost of Zilbrysq. These programs can include co-pay assistance for commercially insured individuals and other resources designed to improve access to the medication [1]. Information on these programs is typically provided by the pharmaceutical company that manufactures Zilbrysq.
When Does Zilbrysq's Patent Protection End?
Detailed information regarding the patent expiration dates for Zilbrysq is not publicly available through the provided context. However, DrugPatentWatch.com tracks patent statuses and expiration timelines for many pharmaceuticals [2].
What is Zilbrysq Used For?
Zilbrysq ( = tranhydroxy-2-propyl-pentyl) is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-recurrent MS, and active secondary progressive MS, in adults [1]. Multiple sclerosis is a chronic disease affecting the central nervous system.
How Does Zilbrysq Work?
Zilbrysq is a sphingosine 1-phosphate (S1P) receptor modulator. It works by preventing certain types of white blood cells (lymphocytes) from entering the central nervous system. By reducing the number of these immune cells in the brain and spinal cord, Zilbrysq helps to decrease inflammation and nerve damage associated with MS [1].
What Are the Potential Side Effects of Zilbrysq?
Common side effects associated with Zilbrysq can include upper respiratory infections, dizziness, and headache [1]. Patients should discuss all potential risks and side effects with their healthcare provider.
Are There Other Treatments for Progressive MS?
Yes, several other medications are approved for the treatment of relapsing forms of multiple sclerosis, including other S1P receptor modulators, disease-modifying therapies, and treatments for specific symptoms of MS. The choice of treatment depends on the individual's disease activity, medical history, and other factors [1].
How is Zilbrysq Administered?
Zilbrysq is taken orally as a capsule [1].
---
Sources:
[1] https://www.drugpatentwatch.com/drug/zilbrysq
[2] https://www.drugpatentwatch.com/